These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 19410160)

  • 1. Cardiovascular disease and modifiable cardiometabolic risk factors.
    Cannon CP
    Clin Cornerstone; 2008; 9(2):24-38; discussion 39-41. PubMed ID: 19410160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular disease and modifiable cardiometabolic risk factors.
    Cannon CP
    Clin Cornerstone; 2007; 8(3):11-28. PubMed ID: 18452839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of cardiovascular risk in patients with type 2 diabetes mellitus as a component of the cardiometabolic syndrome.
    Ferdinand KC
    J Cardiometab Syndr; 2006; 1(2):133-40. PubMed ID: 17679832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity-related cardiometabolic complications.
    Cannon CP
    Clin Cornerstone; 2008; 9(1):11-9; discussion 20-2. PubMed ID: 19046736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyslipidemia and glucose dysregulation in overweight and obese patients.
    LeRoith D
    Clin Cornerstone; 2007; 8(3):38-52. PubMed ID: 18452841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of diabetes and associated cardiometabolic risk factors on members: strategies for optimizing outcomes.
    Hoerger TJ; Ahmann AJ
    J Manag Care Pharm; 2008 Feb; 14(1 Suppl C):S2-14; quiz 15-6. PubMed ID: 18240890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity as a cardiovascular risk factor.
    Sowers JR
    Am J Med; 2003 Dec; 115 Suppl 8A():37S-41S. PubMed ID: 14678864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiovascular risk profile in 40-year old men and 50-year old women in the Czech Republic: results of a cross-sectional survey].
    Vrablík M; Chmelík Z; Lánská V
    Vnitr Lek; 2014 Nov; 60(11):991-7. PubMed ID: 25600047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance: the link between obesity and cardiovascular disease.
    Reaven GM
    Med Clin North Am; 2011 Sep; 95(5):875-92. PubMed ID: 21855697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health Benefits of Plant-Based Nutrition: Focus on Beans in Cardiometabolic Diseases.
    Mullins AP; Arjmandi BH
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33562498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of orlistat on cardiovascular disease risk in obese adults.
    Swinburn BA; Carey D; Hills AP; Hooper M; Marks S; Proietto J; Strauss BJ; Sullivan D; Welborn TA; Caterson ID
    Diabetes Obes Metab; 2005 May; 7(3):254-62. PubMed ID: 15811142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and cardiovascular disease. Pathogenetic role of the metabolic syndrome and therapeutic implications.
    Abate N
    J Diabetes Complications; 2000; 14(3):154-74. PubMed ID: 10989324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes and cardiovascular risk markers.
    Erdmann E
    Curr Med Res Opin; 2005; 21 Suppl 1():S21-8. PubMed ID: 15811196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus.
    Rader DJ
    Am J Med; 2007 Mar; 120(3 Suppl 1):S12-8. PubMed ID: 17320517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol goal attainment in hypertensive patients: the impact of metabolic syndrome components.
    Rodrigues CJ; Ribeiro HF; Ribeiro AB; Zanella MT; Batista MC
    Metab Syndr Relat Disord; 2012 Jun; 10(3):195-201. PubMed ID: 22313142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of the obese patient in primary care: targeting and meeting goals and expectations.
    Bray G; Look M; Ryan D
    Postgrad Med; 2013 Sep; 125(5):67-77. PubMed ID: 24113665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renin-angiotensin system inhibitor and statins combination therapeutics - what have we learnt?
    Koh KK; Sakuma I; Hayashi T; Kim SH; Chung WJ
    Expert Opin Pharmacother; 2015 May; 16(7):949-53. PubMed ID: 25747324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-gamma-inducing property.
    Yamagishi S; Takeuchi M
    Med Hypotheses; 2005; 64(3):476-8. PubMed ID: 15617852
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.